Editorial Webinar: The Drug Pricing Debate

The 116th Congress has been sworn in and the Democratic House and Republican Senate are gearing up for a busy year. What policies and personalities should we be watching, and what will Congress focus on before attention turns to the 2020 elections?

The Drug Pricing Debate

July 17th | 11 a.m. EST

Join National Journal health care correspondent Erin Durkin as she breaks down the drug pricing debate from the Hill to the White House. Erin will explore the major players in the health care arena, current proposals to try to bring down the cost of prescription drugs, and other topics including:

The split among House Democrats over a proposal to allow Medicare to negotiate drug prices
How senators are looking to boost the development of generics and biosimilar drugs
Litigation that's keeping biosimilar drugs off the market
Other challenges that lie ahead

The 116th Congress has been sworn in and the Democratic House and Republican Senate are gearing up for a busy year. What policies and personalities should we be watching, and what will Congress focus on before attention turns to the 2020 elections?

Section 3 Headline

Section 3 Point 1

Section 3 Point 2

Section 3 Point 3

Section 4 - Point 1

Section 4 - Point 2

Section 4 - Point 3

Section 5 Title

Section 6 Title

Section 7 Video Title